ORGANIC
LETTERS
2006
Vol. 8, No. 14
2997-3000
Synthesis of the Spirastrellolide A
Trioxadispiroketal
Ce Wang and Craig J. Forsyth*
Department of Chemistry, UniVersity of Minnesota, 207 Pleasant Street SE,
Minneapolis, Minnesota 55414
Received April 19, 2006
ABSTRACT
The core trioxadispiroketal system representing C26−C40 of spirastrellolide A was assembled using a sequenced double-intramolecular hetero-
Michael addition process.
Spirastrellolide A (Figure 1) is a polyketide isolated from
extracts of the Caribbean sponge Spirastrella coccinea.1 This
arrest. The methyl ester of spirastrellolide A also exhibited
potent tubulin-independent activity in a cell-based antimitotic
assay.1a As a structurally novel entrant to the okadaic acid
class of phosphatase inhibitors,4 spirastrellolide A and its
derivatives may have therapeutic potential.
The complete stereochemistry of spirastrellolide A is
undefined, but the relative configurations of three separate
portions were reported.1b Several individual fragments have
also been synthesized.5 We were initially interested in
exploring the double-intramolecular hetero-Michael addition
(DIHMA) process6 for the synthesis of spirastrellolide A’s
trioxadispiroketal domain 1 (Scheme 1).7 This would rep-
resent an extension of this synthetic methodology following
its success in generating the azaspiracid trioxadispiroketal
domain.8
Trioxadispiroketal 1 (Scheme 1) was targeted in an
arbitrary absolute configuration. Establishment of both C31
Figure 1. Two possible diastereomers of spirastrellolide A.
(3) Boger, D. L.; Lewy, D. S.; Gauss, C. M.; Soenen, D. R. Curr. Med.
Chem. 2002, 9, 917.
(4) Sassa, T.; Richter, W. W.; Uda, N.; Suganuma, M.; Suguri, H.;
Yoshizawa, S.; Hirota, M.; Fujiki, H. Biochem. Biophys. Res. Comm. 1989,
159, 939.
(5) (a) Liu, J.; Hsung, R. P. Org. Lett. 2005, 7, 2273. (b) Paterson, I.;
Anderson, E. A.; Dalby, S. M.; Loiseleur, O. Org. Lett. 2005, 7, 4121. (c)
Paterson, I.; Anderson, E. A.; Dalby, S. M.; Loiseleur, O. Org. Lett. 2005,
7, 4125. (d) Pan, Y.; De Brabander, J. K. Synth. Lett. 2006, 6, 853.
(6) Forsyth, C. J.; Hao, J.; Aguaide, J. Angew. Chem., Int. Ed. 2001, 40,
3663.
(7) Wang, C.; Forsyth, C. J. Abstracts of Papers, 229th National Meeting
of the American Chemical Society, San Diego, Mar 13-17, 2005; American
Chemical Society: Washington, DC, 2005; ORGN-414.
natural product inhibits protein phosphatases 1 and 2A with
IC50 values of 50 and 1 nM, respectively. The activities of
spirastrellolide A1b are similar to those of known protein
phosphatase inhibitors, including okadaic acid2 and fostrie-
cin,3 which induce premature entry into mitosis and mitotic
(1) (a) Williams, D. E.; Roberge, M.; Van Soest, R.; Andersen, R. J. J.
Am. Chem. Soc. 2003, 125, 5296. (b) Williams, D. E.; Lapawa, M.; Feng,
X.; Tarling, T.; Roberge, M.; Andersen, R. J. Org. Lett. 2004, 6, 2607.
(2) Dounay, A. B., Forsyth, C. J. Curr. Med. Chem. 2002, 9, 1951.
10.1021/ol0609457 CCC: $33.50
© 2006 American Chemical Society
Published on Web 06/15/2006